Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial.
Ruggenenti P, Cravedi P, Gotti E, Plati A, Marasà M, Sandrini S, Bossini N, Citterio F, Minetti E, Montanaro D, Sabadini E, Tardanico R, Martinetti D, Gaspari F, Villa A, Perna A, Peraro F, Remuzzi G. Ruggenenti P, et al. Among authors: citterio f. PLoS Med. 2021 Jun 24;18(6):e1003668. doi: 10.1371/journal.pmed.1003668. eCollection 2021 Jun. PLoS Med. 2021. PMID: 34166370 Free PMC article. Clinical Trial.
Incidence of second primary cancer in transplanted patients.
Taioli E, Piselli P, Arbustini E, Boschiero L, Burra P, Busnach G, Caldara R, Citterio F, De Juli E, Dissegna D, Gotti E, Marchini F, Maresca MC, Marsano L, Montagnino G, Montanaro D, Sandrini S, Pedotti P, Scalamogna M, Serraino D. Taioli E, et al. Among authors: citterio f. Transplantation. 2006 Apr 15;81(7):982-5. doi: 10.1097/01.tp.0000203321.42121.14. Transplantation. 2006. PMID: 16612272
Prospective clinical trial comparing two immunosuppressive regimens, tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine, in de novo renal transplant recipients: results at 6 months follow-up.
Favi E, Citterio F, Spagnoletti G, Gargiulo A, Delreno F, Romagnoli J, Castagneto M. Favi E, et al. Among authors: citterio f. Transplant Proc. 2009 May;41(4):1152-5. doi: 10.1016/j.transproceed.2009.03.019. Transplant Proc. 2009. PMID: 19460503 Clinical Trial.
Cardiovascular risk profile in kidney transplant recipients treated with two immunosuppressive regimens: tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine.
Spagnoletti G, Citterio F, Favi E, Rossi E, Delreno F, De Santis I, Salerno MP, Gargiulo A, Castagneto M. Spagnoletti G, et al. Among authors: citterio f. Transplant Proc. 2009 May;41(4):1175-7. doi: 10.1016/j.transproceed.2009.03.045. Transplant Proc. 2009. PMID: 19460509
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial.
Salvadori M, Scolari MP, Bertoni E, Citterio F, Rigotti P, Cossu M, Dal Canton A, Tisone G, Albertazzi A, Pisani F, Gubbiotti G, Piredda G, Busnach G, Sparacino V, Goepel V, Messa P, Berloco P, Montanaro D, Veroux P, Federico S, Bartezaghi M, Corbetta G, Ponticelli C. Salvadori M, et al. Among authors: citterio f. Transplantation. 2009 Nov 27;88(10):1194-202. doi: 10.1097/TP.0b013e3181bb43ec. Transplantation. 2009. PMID: 19935373 Free article. Clinical Trial.
Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009.
Piselli P, Serraino D, Segoloni GP, Sandrini S, Piredda GB, Scolari MP, Rigotti P, Busnach G, Messa P, Donati D, Schena FP, Maresca MC, Tisone G, Veroux M, Sparacino V, Pisani F, Citterio F; Immunosuppression and Cancer Study Group. Piselli P, et al. Among authors: citterio f. Eur J Cancer. 2013 Jan;49(2):336-44. doi: 10.1016/j.ejca.2012.09.013. Epub 2012 Oct 10. Eur J Cancer. 2013. PMID: 23062667
219 results